- Report
- June 2025
- 150 Pages
Global
From €5252EUR$5,950USD£4,527GBP
- Report
- June 2025
- 220 Pages
Global
From €2207EUR$2,500USD£1,902GBP
- Report
- January 2026
- 197 Pages
Global
From €3129EUR$3,545USD£2,697GBP
€3477EUR$3,939USD£2,997GBP
- Report
- January 2026
- 182 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- January 2026
- 182 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- January 2026
- 182 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- January 2026
- 181 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- November 2025
- 185 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- November 2025
- 185 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- November 2025
- 180 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- November 2025
- 183 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- August 2025
- 181 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- June 2025
- 185 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- May 2025
- 187 Pages
Global
From €3972EUR$4,500USD£3,424GBP
- Report
- January 2026
- 191 Pages
Global
From €3129EUR$3,545USD£2,697GBP
€3477EUR$3,939USD£2,997GBP
- Report
- January 2026
- 180 Pages
Global
From €3129EUR$3,545USD£2,697GBP
€3477EUR$3,939USD£2,997GBP
- Report
- January 2026
- 193 Pages
Global
From €3129EUR$3,545USD£2,697GBP
€3477EUR$3,939USD£2,997GBP
- Report
- January 2026
- 195 Pages
Global
From €3129EUR$3,545USD£2,697GBP
€3477EUR$3,939USD£2,997GBP
- Report
- January 2026
- 198 Pages
Global
From €3129EUR$3,545USD£2,697GBP
€3477EUR$3,939USD£2,997GBP
- Report
- January 2026
- 199 Pages
Global
From €3129EUR$3,545USD£2,697GBP
€3477EUR$3,939USD£2,997GBP

The Transcriptomics market is a segment of the biotechnology industry that focuses on the study of gene expression. It involves the analysis of the transcriptome, which is the set of all RNA molecules in a cell. This includes mRNA, tRNA, and rRNA. Transcriptomics is used to study gene expression, regulation, and function. It is used to identify and characterize genes, as well as to understand the role of genes in disease and development. Transcriptomics can also be used to identify biomarkers for diagnosis and prognosis, and to develop new therapeutic targets.
Some companies in the Transcriptomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and QIAGEN. Show Less Read more